Edited by George M. CarmanCardiolipin (CL), the signature phospholipid of mitochondrial membranes, plays an important role in mitochondrial processes and bioenergetics. CL is synthesized de novo and undergoes remodeling in the mitochondrial membranes. Perturbation of CL remodeling leads to the rare X-linked genetic disorder Barth syndrome, which shows disparities in clinical presentation. To uncover biochemical modifiers that exacerbate CL deficiency, we carried out a synthetic genetic array screen to identify synthetic lethal interactions with the yeast CL synthase mutant crd1⌬. The results indicated that crd1⌬ is synthetically lethal with mutants in pyruvate dehydrogenase (PDH), which catalyzes the conversion of pyruvate to acetyl-CoA. Acetyl-CoA levels were decreased in the mutant. The synthesis of acetylCoA depends primarily on the PDH-catalyzed conversion of pyruvate in the mitochondria and on the PDH bypass in the cytosol, which synthesizes acetyl-CoA from acetate. Consistent with perturbation of the PDH bypass, crd1⌬ cells grown on acetate as the sole carbon source exhibited decreased growth, decreased acetyl-CoA, and increased intracellular acetate levels resulting from decreased acetyl-CoA synthetase activity. PDH mRNA and protein levels were up-regulated in crd1⌬ cells, but PDH enzyme activity was not increased, indicating that PDH up-regulation did not compensate for defects in the PDH bypass. These findings demonstrate for the first time that CL is required for acetyl-CoA synthesis, which is decreased in CL-deficient cells as a result of a defective PDH bypass pathway.
Cardiolipin (CL)4 is a unique phospholipid with dimeric structure that constitutes about 15% of the total phospholipid in mitochondria (1-4). CL is synthesized de novo in the inner mitochondrial membrane (5) and undergoes remodeling in which saturated fatty acyl chains are replaced with unsaturated fatty acids (6, 7). CL plays an important role in maintenance of mitochondrial structure, interaction with mitochondrial membrane proteins, respiration and stability of respiratory chain supercomplexes (8 -10), and other mitochondrial functions such as protein import and maintenance of the membrane potential (11-13). Loss of CL perturbs mitochondrial bioenergetics and decreases ATP synthesis (12, 14 -16). Aberrant CL remodeling due to mutation of tafazzin, the transacylase that remodels CL, leads to the severe genetic disorder Barth syndrome (BTHS) (17). Loss of tafazzin results in decreased total CL, increased monolysocardiolipin, and aberrant CL species (18 -20). In yeast, tafazzin mutant phenotypes are not due to aberrant CL species but more likely result from decreased total CL/increased monolysocardiolipin (21, 22). The clinical presentation of BTHS includes cardio-and skeletal myopathy, neutropenia, 3-methylglutaconic aciduria, growth retardation, abnormal mitochondria, and defective oxidative phosphorylation (23). However, disparities in the clinical manifestation are characteristic of the disorder (24 -26), indicating that physiologi...